| Primary information |
|---|
| sequence ID | Seq_9461 |
| Peptide sequence | VVSLGSPSGEVSHPR |
| CancerPDF_ID | CancerPDF_ID1663, CancerPDF_ID8094, CancerPDF_ID8669, |
| PMID | 21136997,24982608,24618180 |
| Protein Name | Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein |
| UniprotKB Entry Name | FETUA_HUMAN,FETUA_HUMAN,FETUA_HUMAN |
| Fluid | Serum,Urine,Serum |
| M/Z | 1506.77906,NA,1505 |
| Charge | 1,NA,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,Nano-LC-MS,MALDI-TOF |
| Peptide Identification technique | LC-MS-MS/MS,MS/MS,MB- MALDI-TOF |
| Quantification Technique | LC-ESI-MS,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,0.01,NA |
| CancerPDF_ID | CancerPDF_ID1663, CancerPDF_ID8094, CancerPDF_ID8669, |
| p-Value | NA,NA,less than 0.05 |
| Software | MASCOT(v. 2.2.01),"GPM search engine, MASCOT",ClinProTools |
| Length | 15,15,15 |
| Cancer Type | Colorectal cancer,Ovarian cancer,Colorectal cancer |
| Database | SwissProt Database,IPI 3.71 Human Database ,Sequest IPI Human 3.45 |
| Modification | NA,NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,6 Ovarian cancer patients and 6 normal individuals,72 colorectal cancer patient and 70 healthy. For model construction 35 healthy and 36 colorectal cancer patient were choosen and for validation 35 healthy and 36 colorectal cancer. |
| Regulation | NA,Uniquely present in case of urine of ovarian cancer patients,Diffrentially expressed |
| Validation | Leave One out Cross validation,NA,Independent validation |
| Sensitivity | NA,NA,0.9444 |
| Specificity | NA,NA,0.9429 |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |